Subcutaneous · GLP-1 / glucagon dual
AZD9550
6 trials in this molecule. Source: ClinicalTrials.gov, as of July 1, 2026.
Trials
6
Active
5
Recruiting
4
Completed
1
Sites
72
Countries
9
Endpoints
147
Composite endpoints
0
Distinct sites and countries across this molecule's trials. A site running several of its trials counts once, matching the map.
Development
Where the program stands
Trials by phase
Phase 1
3
Phase 1/2
1
Phase 2
2
Trials by status
Recruiting
4
Active, not recruiting
1
Completed
1
Evidence coverage
What this asset has been measured on
Endpoints grouped into outcome categories, ranked by how often they are measured across this asset's trials.
Safety / tolerability / PK
65
Glycemic / diabetes
23
Other (unclassified)
22
Weight & body composition
19
MASH / liver
10
Other clinical outcomes
5
Cardiometabolic biomarkers
3
Most-measured metrics
Top 20 metrics across this asset's endpoints
Trials
Programs for this asset
Every trial for this molecule, with the same search, filters, and sort as the Trials tab.
⌘K
6 of 6